Biotech · Private company
Proteostasis Therapeutics, Inc.
Track this companyFree. Adds Proteostasis Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- PTI-428Phase 2 · Cystic FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- PTI-428Phase 2 · Healthy Volunteer - CompleteClinicalTrials.gov · fetched Nov 12, 2026
- PTI-801Phase 2 · Healthy Volunteer - CompleteClinicalTrials.gov · fetched Nov 12, 2026
- PTI-808Phase 2 · Healthy Volunteer - CompleteClinicalTrials.gov · fetched Nov 12, 2026
- PTI-801Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- PTI-808Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic FibrosisPHASE2 · COMPLETED · started Aug 21, 2018ClinicalTrials.gov NCT03591094 · fetched Nov 12, 2026
- Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic FibrosisPHASE1_PHASE2 · COMPLETED · started Jul 17, 2017ClinicalTrials.gov NCT03251092 · fetched Nov 12, 2026
- Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic FibrosisPHASE1 · COMPLETED · started Apr 10, 2017ClinicalTrials.gov NCT03140527 · fetched Nov 12, 2026
- Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic FibrosisPHASE1_PHASE2 · COMPLETED · started Jul 19, 2016ClinicalTrials.gov NCT02718495 · fetched Nov 12, 2026